Incubation Agreement with CDFD Technology Incubator – May 7, 2024
“Strengthening Our Scientific Foundation in Biomaterials and Advanced Research”
On May 7, 2024, Promecens entered an incubation agreement with the Centre for DNA Fingerprinting and Diagnostics (CDFD) Technology Incubator. This partnership provides us access to one of India’s most advanced research institutions, enabling us to refine our high-purity melanin extraction techniques and biomaterial research.
Why CDFD ?
CDFD is an internationally recognized center of excellence in molecular diagnostics, genomics, and biotechnology research. By joining its technology incubator, Promecens benefits from:
- High-precision molecular biology and biochemical analysis tools for advanced material characterization
- Access to leading scientists and domain experts in biomaterials and genetic research
- A cutting-edge research environment that fosters innovation and scientific rigor
How This Partnership Advances Our Research ?
As part of this incubation, we are actively working on:
- Developing next-generation melanin-based functional materials with superior electronic, optical, and thermal properties
- Refining our proprietary melanin extraction process using advanced biochemical and molecular characterization
- Establishing robust quality control and validation frameworks to ensure consistent high-purity melanin production
This partnership is a significant enabler in our long-term strategy to bridge fundamental research with industrial applications, positioning Promecens at the forefront of sustainable biomaterial innovation.